Neuropeptide Y (NPY) Regulation of Nociceptors
NCT00596193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2012-03-08
Summary
Neuropeptide Y (NPY) potently inhibits pain neurons in rats, but does this occur in human pain neurons? This hypothesis will be tested using microdialysis probes in patients who elect to have root canal treatment or extraction of thier tooth.
Conditions
Sponsors & Collaborators
-
The University of Texas Health Science Center at San Antonio
lead OTHER
Principal Investigators
-
Kenneth M Hargreaves, DDS,PhD · The University of Texas Health Science Center at San Antonio
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-05-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-05-31
Countries
- United States
Study Locations
More Related Trials
-
Does RPNI Reduce Incidence of Neuroma Formation Following Sural Nerve Biopsy
NCT06754969 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
NCT04801498 ·Status: COMPLETED
-
A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers
NCT00912262 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
NCT01096966 ·Status: COMPLETED ·Phase: PHASE2
-
Neurotropin to Treat Chronic Neuropathic Pain
NCT00006289 ·Status: TERMINATED ·Phase: PHASE2
-
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
NCT00916942 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects
NCT04991909 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
NCT00528216 ·Status: COMPLETED ·Phase: PHASE1
-
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
NCT05074485 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
NCT01053845 ·Status: COMPLETED ·Phase: PHASE1
-
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
NCT06420765 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Sensory Testing of the Lower Lip After Inferior Alveolar Nerve Block, and Evaluation of the Role of the Contra-lateral Inferior Alveolar Nerve
NCT01530074 ·Status: TERMINATED ·Phase: NA
-
The Effect of Epidural Steroid Use in Patients With Continous Epidural Block in PHN Patients.
NCT03995563 ·Status: UNKNOWN ·Phase: PHASE4
-
Remote Ischemic Preconditioning Mechanism Study
NCT01541436 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Capsaicin-induced Pain on Homeostatic Plasticity in Healthy Human Participants
NCT04485689 ·Status: UNKNOWN ·Phase: NA
-
A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain
NCT05661734 ·Status: COMPLETED ·Phase: PHASE3
-
Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain
NCT03658018 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia
NCT00373893 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
NCT01669967 ·Status: COMPLETED ·Phase: NA
-
Effect of Abdominal Wall Injections on Abdominal Pain
NCT06121466 ·Status: RECRUITING ·Phase: PHASE4
-
Analgecine for Treatment of Low Back Pain
NCT02168010 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
NCT06247813 ·Status: RECRUITING ·Phase: PHASE2
-
IV Lidocaine Infusion for Neuropathic Pain
NCT05731739 ·Status: WITHDRAWN
-
A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
NCT04026568 ·Status: TERMINATED ·Phase: PHASE2/PHASE3